drugset / Trial / NCT03960866

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

NCT03960866

Phase 2 Completed 39 enrolled Ocuphire Pharma, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of this study are: * To evaluate the efficacy of Phentolamine Mesylate to lower intra-ocular pressure (IOP) in the treatment of Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT). * To evaluate the ocular and systemic safety of Phentolamine Mesylate compared to its vehicle. * To evaluate additional efficacy of Phentolamine Mesylate to improve visual performance.

Timeline

Start
2019-05-28
Primary completion
2019-09-11
Completion
2019-09-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule 1 % Topical